Khan, Muhammad Shahzeb
Vaduganathan, Muthiah
Article History
Accepted: 10 September 2020
First Online: 11 October 2020
Compliance with Ethical Standards
:
: Muhammad Shahzeb Khan has no disclosures to report. Muthiah Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (NIH/NCATS Award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, Cytokinetics, and Relypsa; and participates on clinical endpoint committees for studies sponsored by Galmed, Novartis, and the NIH.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.